SEARCH

SEARCH BY CITATION

References

  • Adams, W. H., Daniel, G. B., Legendre, A. M., Gompf, R. E. & Grove, C. A. (1997) Changes in renal function in cats following treatment of hyperthyroidism using 131I. Veterinary Radiology and Ultrasound 38, 231-238
  • Arikan, S., Tuzcu, A., Gokalp, D., Bahceci, M. & Danis, R. (2007) Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction. Clinical Endocrinology 67, 202-207
  • Biondi, B., Palmieri, E. A., Lombardi, G. & Fazio, S. (2002) Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 87, 968-974
  • Boag, A. K., Neiger, R., Slater, L., Stevens, K. B., Haller, M. & Church, D. B. (2007) Changes in the glomerular filtration rate of 27 cats with hyperthyroidism after treatment with radioactive iodine. Veterinary Record 161, 711-715
  • Boswood, A., Attree, S. & Page, K. (2003) Clinical validation of a proANP 31–67 fragment ELISA in the diagnosis of heart failure in the dog. Journal of Small Animal Practice 44, 104-108
  • Boswood, A., Dukes-McEwan, J., Loureiro, J., James, R. A., Martin, M., Stafford-Johnson, M., Smith, P., Little, C. & Attree, S. (2008) The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease. Journal of Small Animal Practice 49, 26-32
  • Broussard, J. D., Peterson, M. E. & Fox, P. R. (1995) Changes in clinical and laboratory findings in cats with hyperthyroidism from 1983 to 1993. Journal of the American Veterinary Medical Association 206, 302-305
  • Carvalho-Bianco, S. D., Kim, B. W., Zhang, J. X., Harney, J. W., Ribeiro, R. S., Gereben, B., Bianco, A. C., Mende, U. & Larsen, P. R. (2004) Chronic cardiac-specific thyrotoxicosis increases myocardial beta-adrenergic responsiveness. Molecular Endocrinology 18, 1840-1849
  • Connolly, D. J. (2010) Natriuretic peptides: the feline experience. Veterinary Clinics of North America Small Animal Practice 40, 559-570
  • Connolly, D. J., Guitian, J., Boswood, A. & Neiger, R. (2005) Serum troponin I levels in hyperthyroid cats before and after treatment with radioactive iodine. Journal of Feline Medicine and Surgery 7, 289-300
  • Connolly, D. J., Magalhaes, R. J., Syme, H. M., Boswood, A., Fuentes, V. L., Chu, L. & Metcalf, M. (2008) Circulating natriuretic peptides in cats with heart disease. Journal of Veterinary Internal Medicine 22, 96-105
  • Connolly, D. J., Soares Magalhaes, R. J., Fuentes, V. L., Boswood, A., Cole, G., Boag, A. & Syme, H. M. (2009) Assessment of the diagnostic accuracy of circulating natriuretic peptide concentrations to distinguish between cats with cardiac and non-cardiac causes of respiratory distress. Journal of Veterinary Cardiology 11(Suppl 1), S41-50
  • DeFrancesco, T. C., Rush, J. E., Rozanski, E. A., Hansen, B. D., Keene, B. W., Moore, D. T. & Atkins, C. E. (2007) Prospective clinical evaluation of an ELISA B-type natriuretic peptide assay in the diagnosis of congestive heart failure in dogs presenting with cough or dyspnea. Journal of Veterinary Internal Medicine 21, 243-250
  • Diekman, M. J., Harms, M. P., Endert, E., Wieling, W. & Wiersinga, W. M. (2001) Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients. European Journal of Endocrinology 144, 339-346
  • Ertugrul, D. T., Yavuz, B., Ata, N., Yalcin, A. A., Kucukazman, M., Algul, B., Dal, K., Akin, K. O., Deveci, O. S., Canbolat, N., Ure, O. S. & Tutal, E. (2009) Decreasing brain natriuretic peptide levels after treatment for hyperthyroidism. Endocrine Journal 56, 1043-1048
  • Fazio, S., Palmerieri, E. A., Lombardi, G. & Biondi, B. (2004) Effects of thyroid hormone on the cardiovascular system. Recent Progress in Hormone Research 59, 31-59
  • Fine, D. M., Declue, A. E. & Reinero, C. R. (2008) Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease. Journal of the American Veterinary Medical Association 232, 1674-1679
  • Fox, P. R., Oyama, M. A., Reynolds, C., Rush, J. E., DeFrancesco, T. C., Keene, B. W., Atkins, C. E., Macdonald, K. A., Schober, K. E., Bonagura, J. D., Stepien, R. L., Kellihan, H. B., Nguyenba, T. P., Lehmkuhl, L. B., Lefbom, B. K., Moise, N. S. & Hogan, D. F. (2009) Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats. Journal of Veterinary Cardiology 11(Suppl 1), S51-61
  • Fox, P. R., Rush, J. E., Reynolds, C. A., Defrancesco, T. C., Keene, B. W., Atkins, C. E., Gordon, S. G., Schober, K. E., Bonagura, J. D., Stepien, R. L., Kellihan, H. B., Macdonald, K. A., Lehmkuhl, L. B., Nguyenba, T. P., Sydney Moise, N., Lefbom, B. K., Hogan, D. F. & Oyama, M. A. (2011) Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats. Journal of Veterinary Internal Medicine 25, 1010-1016
  • Januzzi, J. L. Jr., Camargo, C. A., Anwaruddin, S., Baggish, A. L., Chen, A. A., Krauser, D. G., Tung, R., Cameron, R., Nagurney, J. T., Chae, C. U., Lloyd-Jones, D. M., Brown, D. F., Foran-Melanson, S., Sluss, P. M., Lee-Lewandrowski, E. & Lewandrowski, K. B. (2005) The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. American Journal of Cardiology 95, 948-954
  • Jepson, R. E., Elliott, J., Brodbelt, D. & Syme, H. M. (2007) Effect of control of systolic blood pressure on survival in cats with systemic hypertension. Journal of Veterinary Internal Medicine 21, 402-409
  • Kahaly, G. J. & Dillmann, W. H. (2005) Thyroid hormone action in the heart. Endocrine Reviews 26, 704-728
  • Kato, K., Murakami, H., Isozaki, O., Tsushima, T. & Takano, K. (2009) Serum concentrations of BNP and ANP in patients with thyrotoxicosis. Endocrine Journal 56, 17-27
  • Klein, I. & Danzi, S. (2007) Thyroid disease and the heart. Circulation 116, 1725-1735
  • Lalor, S. M., Connolly, D. J., Elliott, J. & Syme, H. M. (2009) Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease. Journal of Veterinary Cardiology 11(Suppl 1), S71-79
  • Levin, E. R., Gardner, D. G. & Samson, W. K. (1998) Natriuretic peptides. New England Journal of Medicine 339, 321-328
  • Liang, F., Webb, P., Marimuthu, A., Zhang, S. & Gardner, D. G. (2003) Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endothelin-dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes. Journal of Biological Chemistry 278, 15073-15083
  • Liu, Z. L., Wiedmeyer, C. E., Sisson, D. D. & Solter, P. F. (2002) Cloning and characterization of feline brain natriuretic peptide. Gene 292, 183-190
  • Luchner, A., Muders, F., Dietl, O., Friedrich, E., Blumberg, F., Protter, A. A., Riegger, G. A. & Elsner, D. (2001) Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction. Cardiovascular Research 51, 601-607
  • MacDonald, K. A., Kittleson, M. D., Munro, C. & Kass, P. (2003) Brain natriuretic peptide concentration in dogs with heart disease and congestive heart failure. Journal of Veterinary Internal Medicine 17, 172-177
  • MacLean, H. N., Abbott, J. A., Ward, D. L., Huckle, W. R., Sisson, D. D. & Pyle, R. L. (2006) N-terminal atrial natriuretic peptide immunoreactivity in plasma of cats with hypertrophic cardiomyopathy. Journal of Veterinary Internal Medicine 20, 284-289
  • Mark, P. B., Stewart, G. A., Gansevoort, R. T., Petrie, C. J., McDonagh, T. A., Dargie, H. J., Rodger, R. S. & Jardine, A. G. (2006) Diagnostic potential of circulating natriuretic peptides in chronic kidney disease. Nephrology Dialysis Transplantation 21, 402-410
  • Mori, Y., Nishikawa, M., Matsubara, H., Takagi, T., Toyoda, N., Oikawa, S. & Inada, M. (1990) Stimulation of rat atrial natriuretic peptide (rANP) synthesis by triiodothyronine and thyroxine (T4): T4 as a prohormone in synthesizing rANP. Endocrinology 126, 466-471
  • Mueller, C., Scholer, A., Laule-Kilian, K., Martina, B., Schindler, C., Buser, P., Pfisterer, M. & Perruchoud, A. P. (2004) Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. New England Journal of Medicine 350, 647-654
  • Muenster, J. J., Graettinger, J. S. & Campbell, J. A. (1959) Correlation of clinical and hemodynamic findings in patients with systemic arteriovenous fistulas. Circulation 20, 1079-1086
  • Ojamaa, K., Klemperer, J. D. & Klein, I. (1996) Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 6, 505-512
  • Oyama, M. A., Fox, P. R., Rush, J. E., Rozanski, E. A. & Lesser, M. (2008) Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity. Journal of the American Veterinary Medical Association 232, 1496-1503
  • Park, K. W., Dai, H. B., Ojamaa, K., Lowenstein, E., Klein, I. & Sellke, F. W. (1997) The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anaesthesia Analgesia 85, 734-738
  • Peterson, M. E. & Ward, C. R. (2007) Etiopathologic findings of hyperthyroidism in cats. Veterinary Clinics of North America Small Animal Practice 37, 633-645
  • Prosek, R., Sisson, D. D., Oyama, M. A. & Solter, P. F. (2007) Distinguishing cardiac and non-cardiac dyspnea in 48 dogs using plasma atrial natriuretic factor, B-type natriuretic factor, endothelin, and cardiac troponin-I. Journal of Veterinary Internal Medicine 21, 238-242
  • Raffan, E., Loureiro, J., Dukes-McEwan, J., Fonfara, S., James, R., Swift, S., Bexfield, N., Herrtage, M. E. & Archer, J. (2009) The cardiac biomarker NT-proBNP is increased in dogs with azotemia. Journal of Veterinary Internal Medicine 23, 1184-1189
  • Schmidt, M. K., Reynolds, C. A., Estrada, A. H., Prosek, R., Maisenbacher, H. W., Sleeper, M. M. & Oyama, M. A. (2009) Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: a pilot study. Journal of Veterinary Cardiology 11(Suppl 1), S81-86
  • Schultz, M., Faber, J., Kistorp, C., Jarlov, A., Pedersen, F., Wiinberg, N. & Hildebrandt, P. (2004) N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states. Clinical Endocrinology Oxford 60, 54-59
  • Syme, H. M. (2007) Cardiovascular and renal manifestations of hyperthyroidism. Veterinary Clinics of North America Small Animal Practice 37, 723-743
  • Syme, H. M. & Elliott, J. (2003) The prevalence of hypertension in hyperthyroid cats at diagnosis and following treatment. Journal of Veterinary Internal Medicine 17, 754-755
  • Yasue, H., Yoshimura, M., Sumida, H., Kikuta, K., Kugiyama, K., Jougasaki, M., Ogawa, H., Okumura, K., Mukoyama, M. & Nakao, K. (1994) Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90, 195-203
  • Yoshimura, M., Yasue, H., Okumura, K., Ogawa, H., Jougasaki, M., Mukoyama, M., Nakao, K. & Imura, H. (1993) Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 87, 464-469